Custirsen Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00327340Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC
NCT00138918Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer